| Positive Sign | Negative Sign | p1 | p2 | ||
---|---|---|---|---|---|---|
 | Hyperalgesia | Hypoalgesia | All | |||
Lower-aged (n = 19) | ||||||
 Middle Deltoid | 6 (31.58%)a | 2 (10.53%)b | 8 (42.11%) | 11 (57.89%)b | 0.013* | 0.091 |
 Biceps Brachii | 0 (0) | 5 (26.32%) | 5 (26.32%) | 14 (73.68%) | 0.642 | 0.743 |
 Erector Spinae L2 | 0 (0) | 1 (5.26%) | 1 (5.26%) | 18 (94.74%) | 1.000 | 1.000 |
 Erector Spinae L4 | 0 (0) | 2 (10.53%) | 2 (10.53%) | 17 (89.47%) | 0.492 | 1.000 |
 Rectus Femoris | 1 (5.26%)a | 0 (0)b | 1 (5.26%) | 18 (94.74%) | 0.027* | 0.112 |
 Biceps Femoris | 1 (5.26%) | 0 (0) | 1 (5.26%) | 18 (94.74%) | 0.267 | 0.112 |
 M Gastrocnemius | 1 (5.26%) | 0 (0) | 1 (5.26%) | 18 (94.74%) | 0.148 | 0.205 |
Higher-aged (n = 24) | ||||||
 Middle Deltoid | 0 (0) | 4 (16.67%) | 4 (16.67%) | 20 (83.33%) | N/A | N/A |
 Biceps Brachii | 2 (8.33%) | 6 (25.00%) | 8 (33.33%) | 16 (66.67%) | N/A | N/A |
 Erector Spinae L2 | 0 (0) | 2 (8.33%) | 2 (8.33%) | 22 (91.67%) | N/A | N/A |
 Erector Spinae L4 | 2 (8.33%) | 1 (4.17%) | 3 (12.50%) | 21 (87.50%) | N/A | N/A |
 Rectus Femoris | 0 (0) | 6 (25.00%) | 6 (25.00%) | 18 (75.00%) | N/A | N/A |
 Biceps Femoris | 3 (12.5%) | 3 (12.5%) | 6 (25.00%) | 18 (75.00%) | N/A | N/A |
 M Gastrocnemius | 1 (4.17%) | 4 (16.67%) | 5 (20.83%) | 19 (79.17%) | N/A | N/A |
All Participants (n = 43) | ||||||
 Middle Deltoid | 6 (13.95) | 6 (13.95%) | 12 (27.91%) | 31 (72.09%) | N/A | N/A |
 Biceps Brachii | 2 (4.65%) | 11 (25.58%) | 13 (30.23%) | 30 (69.77%) | N/A | N/A |
 Erector Spinae L2 | 0 (0) | 3 (6.98%) | 3 (6.98%) | 40 (93.02%) | N/A | N/A |
 Erector Spinae L4 | 2 (4.65%) | 3 (6.98%) | 5 (11.63%) | 38 (88.37%) | N/A | N/A |
 Rectus Femoris | 1 (2.33%) | 6 (13.95%) | 7 (16.28%) | 36 (83.72%) | N/A | N/A |
 Biceps Femoris | 4 (9.30%) | 3 (6.98%) | 7 (16.28%) | 36 (83.72%) | N/A | N/A |
 M Gastrocnemius | 2 (4.65%) | 4 (9.30%) | 6 (13.95%) | 37 (86.05%) | N/A | N/A |